secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001493152-23-005722
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals leases new office/lab space and formalizes director compensation
--------------------------------------------------------------------------------

- Leased 2,109 sq ft office/lab in Gaithersburg, MD; term 5.25 years with 3-year extension option; base rent $7,206/month.
- Director agreement with Dr. Milton Brown: $25,000 annual cash, $6,250 for Q4 2022, and option for 25,000 shares at $1.92.
- Lease commences June 1, 2023; building largely occupied by pharma/biotech companies.
- Director agreement effective Jan 1, 2023; Dr. Brown is a founder and former CSO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315223005722/0001493152-23-005722-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315223005722/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005722

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer